New Aspects of Itch Pathophysiology: Component Analysis of Atopic Itch Using the ‘Eppendorf Itch Questionnaire’Darsow U.a · Scharein E.b · Simon D.c · Walter G.c · Bromm B.b · Ring J.a
aDepartment of Dermatology and Allergy Biederstein, Technical University Munich, Munich, bInstitute of Physiology, University Hospital Eppendorf, Hamburg, Germany; cDepartment of Dermatology and Allergy, Alexanderhausklinik, Davos, Switzerland
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Itch represents a leading symptom in dermatological practice with many psychophysiological aspects. Instruments for qualitative registration of these central nervous factors and evaluation of therapeutic measures are still missing. We analyzed in detail the subjective itch sensation in 108 patients with acute atopic eczema with a new questionnaire developed in analogy to the McGill pain questionnaire. The descriptors with the highest load in atopic itch and the most frequent reaction patterns in atopic eczema patients were identified. Itch intensity (mean VAS 62%) and eczema severity (SCORAD mean 41 points) showed a different frequency distribution pattern with a correlation of r = 0.33 (p < 0.05). Principal component analysis of the itch questionnaire data was performed and compared with the standardized SCORAD severity index for the patients with atopic eczema. Three main factors of atopic itch explained 58% of the total variance: (1) ‘suffering’ (correlation with SCORAD, r = 0.6); (2) ‘phasic intensity’ (correlation with SCORAD, r = 0.4), and (3) ‘ecstatic’ component (associated with certain active reaction patterns). In conclusion, the complete description of itch has to consider different factors, which may be described on a more general level by three main components. Two of these are correlated with objective criteria of disease activity.
© 2001 S. Karger AG, Basel
Bromm B: Laboratory animals and human volunteers in the assessment of analgesic efficacy; in Chapman RC, Loeser H (eds): Issues in Pain Measurement. New York, Raven, 1989, pp 117–144.
- Reinauer S, Goertz G: Juckreiz. Hautarzt 1996;47:229–242.
- Hägermark Ö, Wahlgren CF: Some methods of evaluating clinical itch and their application for studying pathophysiological mechanisms. J Dermatol Sci 1992;4:55–62.
Summerfield JA, Welch ME: The measurement of itch with sensitive limb movement meters. Br J Dermatol 1980;102:275–281.
Woodward DF, Conway JL, Wheeler LA: Cutaneous itching models; in Maibach HI, Lowe NJ (eds): Models in Dermatology. Basel, Karger, 1985, vol 1, pp 187–195.
- Bromm B, Scharein E, Darsow U, Ring J: Effects of menthol and cold on histamine-induced itch and skin reactions in man. Neurosci Lett 1995;187:157–160.
- Darsow U, Ring J, Scharein E, Bromm B: Correlations between histamine-induced wheal, flare and itch. Arch Dermatol Res 1996;288:436–441.
- Severity scoring of atopic dermatitis: The SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993;186:23–31.
- Hall EH, Terezhalmy GT, Pelleu GB Jr: A set of descriptors for the diagnosis of dental pain syndromes. Oral Surg Oral Med Oral Pathol 1986;61:153–157.
- Melzack R: The McGill Pain Questionnaire: Major properties and scoring methods. Pain 1975;1:277–299.
- Stein C, Mendl G: The German counterpart to McGill Pain Questionnaire. Pain 1988;32:251–255.
Bernhard JD: Pruritus in skin disease; in Bernhard JD (ed): Itch: Mechanisms and Management of Pruritus. New York, McGraw-Hill, 1994, p 42.
- Darsow U, Mautner V, Scharein E, Bromm B, Ring J: Der Eppendorfer Juckreizfragebogen. Hautarzt 1997;48:730–733.
Droge U, Mautner V, Hoting E: Differenzierung von Pruritusqualitäten. Dtsch Derm 1986;34:919–932.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.